In contrast, IRE1α-XBP1s signaling was necessary for resistance to immunogenic cell death in colorectal cancer cells induced by combinatorial treatment of chemotherapy and cetuximab, a monoclonal antibody that blocks epidermal growth factor receptor (EGFR)-ligand interaction [148]. The gene discussed is EGFR; the disease is colorectal cancer.